Roche (4 pharmaceutical products) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Roche (4 pharmaceutical products) General Information

Description

A portfolio of pharmaceutical products. The portfolio comprises of four products namely Marcoumar, an anticoagulant, Torem , a loop diuretic, Tilcotil , a drug for the treatment of painful inflammatory and degenerative disorders of the musculoskeletal system and Aurorix , a well-known antidepressant.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Grenzacherstrasse 124
  • 4070 Basel
  • Switzerland
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Meda
Corporate Office
  • Grenzacherstrasse 124
  • 4070 Basel
  • Switzerland

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Roche (4 pharmaceutical products) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Roche (4 pharmaceutical products)‘s full profile, request access.

Request a free trial

Roche (4 pharmaceutical products) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Roche (4 pharmaceutical products)‘s full profile, request access.

Request a free trial

Roche (4 pharmaceutical products) FAQs

  • Where is Roche (4 pharmaceutical products) headquartered?

    Roche (4 pharmaceutical products) is headquartered in Basel, Switzerland.

  • What industry is Roche (4 pharmaceutical products) in?

    Roche (4 pharmaceutical products)’s primary industry is Buildings and Property.

  • Is Roche (4 pharmaceutical products) a private or public company?

    Roche (4 pharmaceutical products) is a Private company.

  • What is the current valuation of Roche (4 pharmaceutical products)?

    The current valuation of Roche (4 pharmaceutical products) is 00000.

  • What is Roche (4 pharmaceutical products)’s current revenue?

    The current revenue for Roche (4 pharmaceutical products) is 000000.

  • Who are Roche (4 pharmaceutical products)’s investors?

    Roche has invested in Roche (4 pharmaceutical products).

  • When was Roche (4 pharmaceutical products) acquired?

    Roche (4 pharmaceutical products) was acquired on 15-Aug-2008.

  • Who acquired Roche (4 pharmaceutical products)?

    Roche (4 pharmaceutical products) was acquired by Meda.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »